glp 1 compounding fda New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Pharmacovigilance Assessment of Compounded GLP-1
Description
Uncover how GLP-1 and Ozempic impact diabetes and metabolic health with OnPoint Nutrition's expert guidance.

These one-page guides will answer your patient's most common questions when starting a GLP-1 RA or SGLT2i medication..

Treatment options for patients with type 2 diabetes mellitus have increased with the addition of three new drug classes
MeAgain is food logging built for GLP-1 users.
Explore how GLP-1 medications affect the mind-body connection

Below is a roundup of payer-centric news for the week of Jan
